Letter: Design of clinical trials.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004341:Drug Evaluation / Q000379:methods*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists